{"custom_id": "20251129T045001943Z_gpt-5.1-2025-11-13_seed125__20251129T045001943Z_gpt-5.1-2025-11-13_seed125-001", "method": "POST", "url": "/v1/chat/completions", "body": {"model": "gemini-3-pro-preview", "messages": [{"role": "user", "content": "NOT FOR CLINICAL USE.\nYou are taking a multiple-choice exam. Choose the single best option.\nAt the very end, you MUST write exactly: The answer is (X)\n\nQuestion: A 54-year-old man with decompensated alcoholic cirrhosis (MELD-Na 29) is intubated for acute variceal hemorrhage and started on norepinephrine for hemorrhagic shock. Despite volume resuscitation, blood products, and endoscopic band ligation, he requires increasing vasopressor doses. Continuous renal replacement therapy is initiated for worsening azotemia and hyperkalemia. His MAP is 62 mm Hg on norepinephrine 0.24 mcg/kg/min and vasopressin 0.03 units/min. Lactate is 5.1 mmol/L; pH 7.28; ScvO2 76%. Bedside echo shows hyperdynamic LV function, small underfilled LV, and collapsible IVC. CVP is 4 mm Hg. You are considering adding a third agent. Which vasopressor strategy is most appropriate now?\nOptions:\nA. Add epinephrine infusion targeting higher MAP (70-75 mm Hg)\nB. Add low-dose dobutamine to improve splanchnic perfusion\nC. Add angiotensin II infusion while maintaining current MAP target\nD. Increase vasopressin above 0.04 units/min to exploit V1 receptor effect\nE. Switch norepinephrine to phenylephrine to minimize beta-adrenergic effects\nPick the single best answer.\nOutput MUST end with: The answer is (X)\nUse only one capital letter (A, B, C, D, E)."}], "top_p": 1, "reasoning_effort": "high"}}
{"custom_id": "20251129T045001943Z_gpt-5.1-2025-11-13_seed125__20251129T045001943Z_gpt-5.1-2025-11-13_seed125-002", "method": "POST", "url": "/v1/chat/completions", "body": {"model": "gemini-3-pro-preview", "messages": [{"role": "user", "content": "NOT FOR CLINICAL USE.\nYou are taking a multiple-choice exam. Choose the single best option.\nAt the very end, you MUST write exactly: The answer is (X)\n\nQuestion: A 63-year-old woman with a history of JAK2-positive polycythemia vera treated with hydroxyurea for 9 years presents with 3 months of progressive fatigue, 7-kg weight loss, early satiety, and drenching night sweats. Exam shows marked splenomegaly 12 cm below the costal margin. CBC: Hgb 9.1 g/dL, MCV 96 fL, WBC 18,000/\u00b5L with left shift, platelets 110,000/\u00b5L. Peripheral smear reveals tear-drop cells, nucleated RBCs, and leukoerythroblastosis. LDH is elevated; uric acid is high. Bone marrow aspirate is 'dry'; core biopsy shows hypercellular marrow with grade 3 reticulin fibrosis and atypical megakaryocytic clusters. Cytogenetics: new complex karyotype with monosomy 7. Which is the most appropriate next step in disease-directed management?\nOptions:\nA. Escalate hydroxyurea dose and add low-dose aspirin\nB. Start ruxolitinib and defer further planning until spleen size stabilizes\nC. Proceed to allogeneic hematopoietic stem cell transplantation evaluation\nD. Begin azacitidine as first-line therapy for post-PV myelofibrosis\nE. Initiate weekly pegylated interferon alfa-2a for cytoreduction\nPick the single best answer.\nOutput MUST end with: The answer is (X)\nUse only one capital letter (A, B, C, D, E)."}], "top_p": 1, "reasoning_effort": "high"}}
{"custom_id": "20251129T045001943Z_gpt-5.1-2025-11-13_seed125__20251129T045001943Z_gpt-5.1-2025-11-13_seed125-003", "method": "POST", "url": "/v1/chat/completions", "body": {"model": "gemini-3-pro-preview", "messages": [{"role": "user", "content": "NOT FOR CLINICAL USE.\nYou are taking a multiple-choice exam. Choose the single best option.\nAt the very end, you MUST write exactly: The answer is (X)\n\nQuestion: A 28-year-old G1P0 woman at 33 weeks' gestation presents to the ED with acute dyspnea, pleuritic chest pain, and near syncope. HR 132/min, BP 82/48 mm Hg, RR 30/min, SpO2 89% on 6 L nasal cannula. Bedside echo reveals a dilated RV with McConnell sign and septal flattening. CTA is unavailable; lower-extremity duplex is pending. She is consentable and has no contraindications to thrombolysis. Fetal heart tones are 150 bpm with moderate variability. Which management is most appropriate now?\nOptions:\nA. Systemic thrombolysis with weight-based alteplase bolus and infusion\nB. Urgent catheter-directed thrombolysis with reduced-dose alteplase\nC. Immediate transfer for surgical embolectomy with cardiopulmonary bypass\nD. Initiate high-dose unfractionated heparin and defer reperfusion until postpartum\nE. Administer tenecteplase as a single IV bolus followed by heparin\nPick the single best answer.\nOutput MUST end with: The answer is (X)\nUse only one capital letter (A, B, C, D, E)."}], "top_p": 1, "reasoning_effort": "high"}}
{"custom_id": "20251129T045001943Z_gpt-5.1-2025-11-13_seed125__20251129T045001943Z_gpt-5.1-2025-11-13_seed125-004", "method": "POST", "url": "/v1/chat/completions", "body": {"model": "gemini-3-pro-preview", "messages": [{"role": "user", "content": "NOT FOR CLINICAL USE.\nYou are taking a multiple-choice exam. Choose the single best option.\nAt the very end, you MUST write exactly: The answer is (X)\n\nQuestion: A 4-year-old boy is brought to the PICU with progressive leg weakness and refusal to walk for 5 days after a viral upper respiratory infection. Exam: flaccid symmetric weakness in legs > arms, areflexia, intact sensation, no bowel/bladder dysfunction, and no cranial nerve involvement. He can lift his head briefly but cannot stand; FVC is 55% predicted. MRI spine is normal. CSF shows protein 42 mg/dL, 3 WBC/\u00b5L. Nerve conduction studies show reduced CMAP amplitudes with preserved conduction velocities and distal latencies; sensory studies are normal, and F-waves are absent. Which subtype best describes his neuropathy and has implications for prognosis and treatment response?\nOptions:\nA. Acute inflammatory demyelinating polyradiculoneuropathy (AIDP)\nB. Acute motor axonal neuropathy (AMAN) variant of Guillain-Barr\u00e9 syndrome\nC. Acute motor and sensory axonal neuropathy (AMSAN)\nD. Miller Fisher syndrome\nE. Acute flaccid myelitis related to enterovirus D68\nPick the single best answer.\nOutput MUST end with: The answer is (X)\nUse only one capital letter (A, B, C, D, E)."}], "top_p": 1, "reasoning_effort": "high"}}
{"custom_id": "20251129T045001943Z_gpt-5.1-2025-11-13_seed125__20251129T045001943Z_gpt-5.1-2025-11-13_seed125-005", "method": "POST", "url": "/v1/chat/completions", "body": {"model": "gemini-3-pro-preview", "messages": [{"role": "user", "content": "NOT FOR CLINICAL USE.\nYou are taking a multiple-choice exam. Choose the single best option.\nAt the very end, you MUST write exactly: The answer is (X)\n\nQuestion: A 47-year-old man with poorly controlled type 2 diabetes and daily alcohol use presents with 10 days of fever, right-sided headache, and progressive confusion. He was treated with oral amoxicillin-clavulanate for presumed sinusitis without improvement. On exam he is disoriented, febrile (38.8\u00b0C), with mild left hemiparesis and papilledema. CT head with contrast shows a 3.5-cm ring-enhancing lesion in the right frontal lobe with extensive surrounding edema contiguous with opacified frontal sinus. Emergent dexamethasone and broad-spectrum IV antibiotics are started. Neurocritical care team plans operative management. Which surgical approach is most appropriate now?\nOptions:\nA. CT-guided stereotactic needle aspiration of the abscess\nB. Open craniotomy with complete abscess excision and sinus drainage\nC. Endoscopic transnasal drainage of the frontal sinus only\nD. Placement of an external ventricular drain for CSF diversion and observation\nE. Delay surgical intervention; continue maximal medical therapy for 2 weeks\nPick the single best answer.\nOutput MUST end with: The answer is (X)\nUse only one capital letter (A, B, C, D, E)."}], "top_p": 1, "reasoning_effort": "high"}}
{"custom_id": "20251129T045001943Z_gpt-5.1-2025-11-13_seed125__20251129T045001943Z_gpt-5.1-2025-11-13_seed125-006", "method": "POST", "url": "/v1/chat/completions", "body": {"model": "gemini-3-pro-preview", "messages": [{"role": "user", "content": "NOT FOR CLINICAL USE.\nYou are taking a multiple-choice exam. Choose the single best option.\nAt the very end, you MUST write exactly: The answer is (X)\n\nQuestion: A 66-year-old man with COPD and metastatic non-small cell lung cancer (PD-L1 80%) started pembrolizumab 10 weeks ago. He presents with 4 days of worsening exertional dyspnea and dry cough, afebrile, with O2 saturation 90% on room air. CT pulmonary angiography shows no embolus but reveals new bilateral, patchy ground-glass opacities and reticular changes in the lower lobes with subpleural sparing. There is no infection on extensive workup, BNP is normal, and no cardiac ischemia. He is on no new drugs besides pembrolizumab. How should this complication be graded and managed now?\nOptions:\nA. Grade 1 pneumonitis; continue pembrolizumab with close monitoring only\nB. Grade 2 pneumonitis; hold pembrolizumab and start prednisone 0.5 mg/kg/day\nC. Grade 2 pneumonitis; hold pembrolizumab and start prednisone 1-2 mg/kg/day\nD. Grade 3 pneumonitis; permanently discontinue pembrolizumab and give IV methylprednisolone 1-2 mg/kg/day\nE. Grade 3 pneumonitis; permanently discontinue pembrolizumab and give infliximab immediately without steroids\nPick the single best answer.\nOutput MUST end with: The answer is (X)\nUse only one capital letter (A, B, C, D, E)."}], "top_p": 1, "reasoning_effort": "high"}}
{"custom_id": "20251129T045001943Z_gpt-5.1-2025-11-13_seed125__20251129T045001943Z_gpt-5.1-2025-11-13_seed125-007", "method": "POST", "url": "/v1/chat/completions", "body": {"model": "gemini-3-pro-preview", "messages": [{"role": "user", "content": "NOT FOR CLINICAL USE.\nYou are taking a multiple-choice exam. Choose the single best option.\nAt the very end, you MUST write exactly: The answer is (X)\n\nQuestion: A 9-year-old girl presents with 2 weeks of progressive headache, morning vomiting, and decline in school performance. Exam reveals papilledema, dysmetria, and truncal ataxia. MRI brain shows an enhancing midline posterior fossa mass infiltrating the cerebellar vermis and roof of the fourth ventricle, with obstructive hydrocephalus. After CSF diversion and near-total resection, histology shows small round blue cells with Homer-Wright rosettes. Molecular profiling reveals WNT-activated medulloblastoma, CTNNB1 mutation, and monosomy 6; no metastatic disease on staging. Which adjuvant treatment strategy is most appropriate?\nOptions:\nA. Craniospinal irradiation at standard dose plus multi-agent chemotherapy (high-risk protocol)\nB. Focal posterior fossa irradiation only plus maintenance oral temozolomide\nC. Reduced-dose craniospinal irradiation with posterior fossa boost plus chemotherapy (standard-risk protocol)\nD. Observation only after gross total resection due to favorable WNT subtype\nE. High-dose chemotherapy with autologous stem cell rescue, without craniospinal irradiation\nPick the single best answer.\nOutput MUST end with: The answer is (X)\nUse only one capital letter (A, B, C, D, E)."}], "top_p": 1, "reasoning_effort": "high"}}
{"custom_id": "20251129T045001943Z_gpt-5.1-2025-11-13_seed125__20251129T045001943Z_gpt-5.1-2025-11-13_seed125-008", "method": "POST", "url": "/v1/chat/completions", "body": {"model": "gemini-3-pro-preview", "messages": [{"role": "user", "content": "NOT FOR CLINICAL USE.\nYou are taking a multiple-choice exam. Choose the single best option.\nAt the very end, you MUST write exactly: The answer is (X)\n\nQuestion: A 71-year-old woman with hypertension and atrial fibrillation on rivaroxaban is admitted with sudden onset aphasia and right hemiplegia. CT head is negative for hemorrhage; CTA shows left M1 occlusion. Last rivaroxaban dose was 3 hours ago. Labs: creatinine 0.9 mg/dL, normal platelets, INR 1.2, anti-factor Xa level (rivaroxaban-calibrated) 170 ng/mL. She arrives 70 minutes after symptom onset. You are in a center with neurointerventional capability and access to andexanet alfa and 4-factor PCC. What is the best acute reperfusion strategy?\nOptions:\nA. Administer IV alteplase followed by mechanical thrombectomy\nB. Administer andexanet alfa to reverse rivaroxaban, then give IV alteplase\nC. Proceed directly to mechanical thrombectomy without IV thrombolysis\nD. Give 4-factor PCC then IV alteplase to offset rivaroxaban effect\nE. Defer reperfusion therapy and manage with permissive hypertension alone\nPick the single best answer.\nOutput MUST end with: The answer is (X)\nUse only one capital letter (A, B, C, D, E)."}], "top_p": 1, "reasoning_effort": "high"}}
{"custom_id": "20251129T045001943Z_gpt-5.1-2025-11-13_seed125__20251129T045001943Z_gpt-5.1-2025-11-13_seed125-009", "method": "POST", "url": "/v1/chat/completions", "body": {"model": "gemini-3-pro-preview", "messages": [{"role": "user", "content": "NOT FOR CLINICAL USE.\nYou are taking a multiple-choice exam. Choose the single best option.\nAt the very end, you MUST write exactly: The answer is (X)\n\nQuestion: A 22-year-old man with sickle cell disease (HbSS) presents with high fever, cough, and pleuritic chest pain. CXR shows new multilobar infiltrates; oxygen saturation is 93% on 2 L/min nasal cannula. Labs: Hgb 7.2 g/dL (baseline 8.5), WBC 18,000/\u00b5L, platelets 310,000/\u00b5L, reticulocyte count 12%. He is diagnosed with acute chest syndrome and started on broad-spectrum antibiotics, incentive spirometry, and simple transfusion to Hgb 9.5 g/dL. Over 24 hours, oxygen requirement increases to 8 L/min with SpO2 90%, and CXR shows progression to near-complete bilateral airspace opacification. Hgb is now 10.3 g/dL, and he is tachypneic but not yet intubated. Which is the most appropriate next step?\nOptions:\nA. Increase simple transfusions to target Hgb 12 g/dL for better oxygen-carrying capacity\nB. Initiate exchange transfusion targeting HbS <30%\nC. Start high-dose corticosteroids to reduce pulmonary inflammation\nD. Add therapeutic anticoagulation for presumed pulmonary embolism\nE. Intubate and initiate low tidal-volume ventilation, deferring transfusion changes\nPick the single best answer.\nOutput MUST end with: The answer is (X)\nUse only one capital letter (A, B, C, D, E)."}], "top_p": 1, "reasoning_effort": "high"}}
{"custom_id": "20251129T045001943Z_gpt-5.1-2025-11-13_seed125__20251129T045001943Z_gpt-5.1-2025-11-13_seed125-010", "method": "POST", "url": "/v1/chat/completions", "body": {"model": "gemini-3-pro-preview", "messages": [{"role": "user", "content": "NOT FOR CLINICAL USE.\nYou are taking a multiple-choice exam. Choose the single best option.\nAt the very end, you MUST write exactly: The answer is (X)\n\nQuestion: A 58-year-old man with alcohol-related cirrhosis and portal hypertension is admitted with confusion and generalized tonic-clonic seizures. He has been on valproic acid for epilepsy for 5 years without prior complications. Medications include lactulose and spironolactone. Exam: asterixis, disorientation, jaundice, and mild ascites. Labs: Na 130 mmol/L, K 4.2 mmol/L, BUN 10 mg/dL, creatinine 0.7 mg/dL, AST 65 U/L, ALT 40 U/L, total bilirubin 3.8 mg/dL, INR 1.7, ammonia 96 \u00b5mol/L. Serum valproate level is therapeutic, but free valproate level is supratherapeutic; serum carnitine is low, and EEG shows triphasic waves without epileptiform activity. Which is the most appropriate antiseizure management strategy?\nOptions:\nA. Continue valproic acid but lower the dose and optimize lactulose therapy\nB. Discontinue valproic acid and start levetiracetam with IV L-carnitine supplementation\nC. Switch valproic acid to phenytoin with aggressive albumin replacement\nD. Add topiramate to valproic acid to improve seizure control\nE. Continue valproic acid and start rifaximin to reduce ammonia\nPick the single best answer.\nOutput MUST end with: The answer is (X)\nUse only one capital letter (A, B, C, D, E)."}], "top_p": 1, "reasoning_effort": "high"}}
